Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glicrite OD 60mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Eswar Therapeutics Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Glicrite OD 60mg/500mg Tablet ER

Diabetic patients using the extended-release Glicrite OD 60mg/50mg tablet, an anti-diabetic medication, should understand its dual-action mechanism for managing type 2 diabetes in adults. This combination therapy regulates blood glucose, optimally absorbed when ingested with food and consistently taken at the same time daily. Dosage adjustments, determined by your physician based on blood sugar monitoring, might be necessary. Continuous use, even with seemingly controlled blood sugar, is crucial; abrupt cessation increases the risk of complications including hyperglycemia, potentially leading to kidney damage, vision impairment, neuropathy, and limb loss. Remember, Glicrite OD is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; manage this by maintaining regular mealtimes and carrying fast-acting glucose sources. Constipation and vomiting are also possible. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other reported side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, upper respiratory infections, and weight gain. Consult your physician before starting Glicrite OD if you have type 1 diabetes, diabetic ketoacidosis, or significant kidney or liver impairment; pre-existing heart disease also warrants discussion. Similarly, pregnant or breastfeeding individuals must seek medical advice. Regular blood glucose monitoring and periodic blood tests (evaluating blood cell counts and liver function) are recommended by your doctor.

Uses of Glicrite OD 60mg/500mg Tablet ER

Non-insulin-dependent diabetes

Major Benefits of Glicrite OD 60mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glicrite OD 60mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Glicrite OD 60mg/500mg Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glicrite OD 60mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Glicrite OD 60mg/500mg Extended-Release tablet should be taken with a meal.

How Glicrite OD 60mg/500mg Tablet ER works:

Extended-release Gliclazide/Metformin tablets (Glicrite OD 60mg/500mg) combine two diabetes medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glicrite OD 60mg/500mg Extended-Release tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glicrite OD 60mg/500mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glicrite OD 60mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glicrite OD 60mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glicrite OD 60mg/500mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Kidney function should be regularly assessed during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glicrite OD 60mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary for these patients. Medical advice is recommended. A reduced initial dose is typically advised for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glicrite OD 60mg/500mg Tablet ER :

Should you forget a dose of Glicrite OD 60mg/500mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glicrite OD 60mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glicrite OD 60mg/500mg Tablet ER

Glicrite OD 60mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glicrite OD 60mg/500mg Tablet ER commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, may also occur. Prolonged use may result in vitamin B12 deficiency.
Glicrite OD 60mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glicrite OD 60mg/500mg Tablet ER can cause lactic acidosis, a serious, potentially life-threatening condition involving excess lactic acid in the blood (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is less likely in patients without kidney disease, those who don't consume excessive alcohol, and younger individuals. Symptoms such as muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia necessitate immediate discontinuation of Glicrite OD 60mg/500mg Tablet ER and prompt medical attention.
Prolonged use of Glicrite OD 60mg/500mg ER tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glicrite OD 60mg/500mg Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Glicrite OD 60mg/500mg ER tablets and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glicrite OD 60mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glicrite OD 60mg/500mg Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glicrite OD 60mg/500mg Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glicrite OD 60mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glicrite OD 60mg/500mg Tablet ER and seek immediate medical attention.
Prolonged use of Glicrite OD 60mg/500mg Extended-Release tablets can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glicrite OD 60mg/500mg Tablet ER is contraindicated in patients allergic to any of its components or excipients, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining alcohol and Glicrite OD 60mg/500mg ER tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glicrite OD 60mg/500mg Ta...
107
MRP 130
17% off